Study Title
Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG)
Study Details
Description:
The purpose of this study is to see if 18F-fluciclovine (Axumin®) PET imaging is useful and safe in the management of children with High Grade Gliomas. Investigators seek to determine if this imaging will help doctors tell the difference between tumor growth (progression) and other tumor changes that can occur after treatment.
Sponsor:
Children's Hospital of Philadelphia
Contacts:
Ali Nabavizadeh (Principal Investigator)nabavizadehs@chop.edu
215-590-1000
Hannah Andersonhannah.anderson@pennmedicine.upenn.edu
215-590-1000
Government Study Link:
NCT05553041 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468